Linden Josephine 4

4 · Innoviva, Inc. · Filed May 20, 2026

AI-generated summary of this filing

Updated May 20, 2026

Innoviva (INVA) Director Linden Josephine Receives Equity Awards

What Happened

Linden Josephine, a director of Innoviva, was granted equity awards upon her appointment to the board on May 18, 2026. The Form 4 reports three grant entries totaling 24,360 units: 5,733 RSUs (grant A), 9,461 RSUs (grant A), and 9,166 derivative units (options) (grant A). Each grant is reported at $0.00 per share/option (total reported value $0).

Key Details

Transaction date: May 18, 2026; Form 4 filed May 20, 2026 (filed within the typical 2-business-day window).
Reported prices: $0.00 for each grant (standard reporting for awards/options at grant).
Shares/units granted: 5,733 RSUs + 9,461 RSUs + 9,166 derivative/options = 24,360 total.
Shares owned after transaction: Not specified in this Form 4.
Footnotes of note:
- F1: RSUs and non‑statutory stock options were granted upon board appointment.
- F2: The RSUs vest in equal installments on each of the first two anniversaries of May 18, 2026.
- F3: Options and additional RSUs vest at the sooner of the next annual meeting or the one‑year anniversary, subject to continued service; vesting may accelerate for death, disability, or a defined change in control (subject to conditions).

Context

These are equity grants (awards), not open‑market purchases or sales, and are commonly part of board compensation—such grants do not by themselves indicate a director's trading sentiment.
The 9,166-unit "derivative" entry reflects option awards rather than immediate stock ownership; vesting and any exercise would occur later per the plan terms above.

Form 4

Period: 2026-05-18

Director

Transactions

Award
Common Stock
[F1][F2]
2026-05-18+5,733→ 5,733 total
Award
Common Stock
[F1][F3]
2026-05-18+9,461→ 15,194 total
Award
Non-statutory Stock Option
[F1][F3]
2026-05-18+9,166→ 9,166 total
Exercise: $21.80From: 2027-05-18Exp: 2036-05-17→ Common Stock (9,166 underlying)

Footnotes (3)

[F1]The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon their appointment to the Issuer's Board of Directors ("Board") on May 18, 2026 (the "Effective Date").
[F2]The RSUs vest in equal installments on each of the first two anniversaries of the Effective Date.
[F3]Options and additional RSUs were granted and will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of the Effective Date, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such "change in control," death or disability.

Signature

/s/ Josephine Linden|2026-05-20

1 file